Clinical trial

Peripheral and Coronary Endothelial Dysfunction In Type 2diabetic Patients- Role of Metformin

NCT00169624

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2005-10-01

PhasePHASE3

Study timeline

Study start (unknown)2005-10-01Date precision: month

Registry last updated2007-10-05

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Coronary and Peripheral Endothelial Dysfunctionunresolved

Interventions

MetforminDRUG · verified · RxNorm: metformin

GliclazideDRUG

Sponsors & collaborators

Hospices Civils de Lyonlead sponsor

Mapped research locations

LyonFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00169624 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.